| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.4 | 8e-09 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.39 | 3e-08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.24 | 3e-07 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |